Cargando…

Progress and Prospects of Gene Editing in Pluripotent Stem Cells

Applying programmable nucleases in gene editing has greatly shaped current research in basic biology and clinical translation. Gene editing in human pluripotent stem cells (PSCs), including embryonic stem cells (ESCs) and induced pluripotent stem cells (iPSCs), is highly relevant to clinical cell th...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Zhenwu, Bao, Xinyu, Lin, Chao-Po
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10452926/ https://www.ncbi.nlm.nih.gov/pubmed/37626665 http://dx.doi.org/10.3390/biomedicines11082168

Ejemplares similares

Gene Editing in Pluripotent Stem Cells and Their Derived Organoids
por: Zhou, Hang, et al.
Publicado: (2021)

Roles of MicroRNAs in Establishing and Modulating Stem Cell Potential
por: Zhang, Zhenwu, et al.
Publicado: (2019)

Gene editing with ‘pencil’ rather than ‘scissors’ in human pluripotent stem cells
por: Park, Ju-Chan, et al.
Publicado: (2023)

May I Cut in? Gene Editing Approaches in Human Induced Pluripotent Stem Cells
por: Brookhouser, Nicholas, et al.
Publicado: (2017)

Generation and clinical potential of functional T lymphocytes from gene-edited pluripotent stem cells
por: Guo, Rongqun, et al.
Publicado: (2022)

Combining Induced Pluripotent Stem Cells and Genome Editing Technologies for Clinical Applications
por: Chang, Chia-Yu, et al.
Publicado: (2018)

CRISPR-Cas9: a promising tool for gene editing on induced pluripotent stem cells
por: Kim, Eun Ji, et al.
Publicado: (2017)

Gene Editing in Human Pluripotent Stem Cells: Choosing the Correct Path
por: Singh, Amar M., et al.
Publicado: (2015)

 Potential of Gene Editing and Induced Pluripotent Stem Cells (iPSCs) in Treatment of Retinal Diseases 
por: Chuang, Katherine, et al.
Publicado: (2017)

Harnessing the Power of Induced Pluripotent Stem Cells and Gene Editing Technology: Therapeutic Implications in Hematological Malignancies
por: Sidhu, Ishnoor, et al.
Publicado: (2021)

Current status and future perspectives of HLA-edited induced pluripotent stem cells
por: Koga, Keiko, et al.
Publicado: (2020)

A Prospective Treatment Option for Lysosomal Storage Diseases: CRISPR/Cas9 Gene Editing Technology for Mutation Correction in Induced Pluripotent Stem Cells
por: Christensen, Chloe L., et al.
Publicado: (2017)

Application of CRISPR/Cas9 to human-induced pluripotent stem cells: from gene editing to drug discovery
por: De Masi, Claudia, et al.
Publicado: (2020)

Induced Pluripotent Stem Cells and Genome-Editing Tools in Determining Gene Function and Therapy for Inherited Retinal Disorders
por: Benati, Daniela, et al.
Publicado: (2022)

When Long Noncoding RNAs Meet Genome Editing in Pluripotent Stem Cells
por: Chen, Fuquan, et al.
Publicado: (2017)

Genome editing of human pluripotent stem cells to generate human cellular disease models
por: Musunuru, Kiran
Publicado: (2013)

Genome Editing and Human Pluripotent Stem Cell Technologies for in vitro Monogenic Diabetes Modeling
por: Dabi, Yosef Tsegaye, et al.
Publicado: (2022)

Pluripotent stem cells for Parkinson's disease: progress and challenges
por: Zeng, Xianmin, et al.
Publicado: (2013)

G1-phase progression in pluripotent stem cells
por: ter Huurne, Menno, et al.
Publicado: (2021)

Harnessing the Potential of Human Pluripotent Stem Cells and Gene Editing for the Treatment of Retinal Degeneration
por: Ovando-Roche, Patrick, et al.
Publicado: (2017)

Induced Pluripotency and Gene Editing in Disease Modelling: Perspectives and Challenges
por: Seah, Yu Fen Samantha, et al.
Publicado: (2015)

Modeling mitochondrial DNA diseases: from base editing to pluripotent stem‐cell‐derived organoids
por: Tolle, Isabella, et al.
Publicado: (2023)

Pluripotency of induced pluripotent stem cells
por: Kang, Lan, et al.
Publicado: (2012)

Pluripotency of Induced Pluripotent Stem Cells
por: Feng, Chunjing, et al.
Publicado: (2013)

Correction: Zhang, Z.; et al. Roles of MicroRNAs in Establishing and Modulating Stem Cell Potential. Int. J. Mol. Sci. 2019, 20, 3643
por: Zhang, Zhenwu, et al.
Publicado: (2020)

Using Gene Editing to Establish a Safeguard System for Pluripotent Stem-Cell-Based Therapies
por: Wu, Youjun, et al.
Publicado: (2019)

Inherited cardiac diseases, pluripotent stem cells, and genome editing combined—the past, present, and future
por: van den Brink, Lettine, et al.
Publicado: (2019)

Progress and prospects in stem cell therapy
por: Xu, Xiu-ling, et al.
Publicado: (2013)

A Cell-Based Optimised Approach for Rapid and Efficient Gene Editing of Human Pluripotent Stem Cells
por: Cuevas-Ocaña, Sara, et al.
Publicado: (2023)

Progress in Gene-Editing Technology of Zebrafish
por: Li, Yanling, et al.
Publicado: (2021)

Progresses, Challenges, and Prospects of CRISPR/Cas9 Gene-Editing in Glioma Studies
por: Kang, Xianhui, et al.
Publicado: (2023)

The Progress of Induced Pluripotent Stem Cells as Models of Parkinson's Disease
por: Kang, Ji-feng, et al.
Publicado: (2016)

Induced Pluripotent Stem Cells in Huntington’s Disease Research: Progress and Opportunity
por: Tousley, Adelaide, et al.
Publicado: (2016)

Progress in Modeling and Targeting Inner Ear Disorders with Pluripotent Stem Cells
por: Tang, Pei-Ciao, et al.
Publicado: (2020)

Progress of Induced Pluripotent Stem Cell Technologies to Understand Genetic Epilepsy
por: Sterlini, Bruno, et al.
Publicado: (2020)

Generating hematopoietic cells from human pluripotent stem cells: approaches, progress and challenges
por: Zheng, Haiqiong, et al.
Publicado: (2023)

The Role of E3s in Regulating Pluripotency of Embryonic Stem Cells and Induced Pluripotent Stem Cells
por: Wu, Yahong, et al.
Publicado: (2021)

‘Cold shock’ increases the frequency of homology directed repair gene editing in induced pluripotent stem cells
por: Guo, Q., et al.
Publicado: (2018)

Protocol for the design, conduct, and evaluation of prime editing in human pluripotent stem cells
por: Wu, Youjun, et al.
Publicado: (2023)

DICE, an efficient system for iterative genomic editing in human pluripotent stem cells
por: Zhu, Fangfang, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6ejjibt2ntci25vn58397gnal7